Profound Medical (PROF) Operating Leases (2018 - 2026)

Profound Medical has reported Operating Leases for 9 years, with the latest figure at $2.9 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases rose 2026.47% year-over-year to $2.9 million; the trailing twelve-month figure through Mar 2026 stood at $2.9 million (up 2026.47% YoY), and the FY2024 full-year result was $203000.0, down 59.72% from the prior year.
• Operating Leases for Q1 2026 stood at $2.9 million, up from $72000.0 in the prior quarter.
• The five-year high for Operating Leases was $1.1 billion in Q1 2022, with the low at $72000.0 in Q2 2025.
• Average Operating Leases over 5 years is $123.3 million, with a median of $629000.0 recorded in 2023.
• Year-over-year, Operating Leases sank 99.94% in 2024 and jumped 2026.47% in 2026.
• Tracing PROF's Operating Leases over 5 years: stood at $817000.0 in 2022, then plunged by 38.31% to $504000.0 in 2023, then slumped by 59.72% to $203000.0 in 2024, then tumbled by 64.53% to $72000.0 in 2025, then jumped by 3916.67% to $2.9 million in 2026.
• The last three Operating Leases figures came in at $2.9 million (Q1 2026), $72000.0 (Q2 2025), and $136000.0 (Q1 2025), per Business Quant data.

Peer Comparison